Ethanolamine Utilization and Bacterial Microcompartment Formation Are Subject to Carbon Catabolite Repression. 2019

Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus faecalis, a GI commensal and opportunistic pathogen, contains approximately 20 ethanolamine utilization (eut) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in eut gene expression, was a concomitant increase in the number of catabolic bacterial microcompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted cre site in one of the three EA-inducible promoters, PeutS, was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the PeutS promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and cre sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR).IMPORTANCE Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria.

UI MeSH Term Description Entries
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D005809 Genes, Regulator Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for PROTEINS or RNAs which have GENE EXPRESSION REGULATION functions. Gene, Regulator,Regulator Gene,Regulator Genes,Regulatory Genes,Gene, Regulatory,Genes, Regulatory,Regulatory Gene
D005816 Genetic Complementation Test A test used to determine whether or not complementation (compensation in the form of dominance) will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell. Allelism Test,Cis Test,Cis-Trans Test,Complementation Test,Trans Test,Allelism Tests,Cis Tests,Cis Trans Test,Cis-Trans Tests,Complementation Test, Genetic,Complementation Tests,Complementation Tests, Genetic,Genetic Complementation Tests,Trans Tests
D013293 Enterococcus faecalis A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic. Streptococcus Group D,Streptococcus faecalis
D015964 Gene Expression Regulation, Bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Bacterial Gene Expression Regulation,Regulation of Gene Expression, Bacterial,Regulation, Gene Expression, Bacterial
D017353 Gene Deletion A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. Deletion, Gene,Deletions, Gene,Gene Deletions
D057465 Catabolite Repression Process by which micro-organisms adapt quickly to a preferred rapidly-metabolizable intermediate through the inhibition or repression of genes related to CATABOLISM of less preferred source(s). Carbon Catabolite Repression,Carbon Catabolite Repressions,Catabolite Repression, Carbon,Catabolite Repressions,Catabolite Repressions, Carbon,Repression, Carbon Catabolite,Repression, Catabolite,Repressions, Carbon Catabolite,Repressions, Catabolite
D019856 Ethanolamine A viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorimetric reagent, and to remove CO2 and H2S from natural gas and other gases. 2-Aminoethanol,Colamine,Monoethanolamine,2 Aminoethanol

Related Publications

Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
May 2024, Infection and immunity,
Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
April 2024, bioRxiv : the preprint server for biology,
Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
January 2002, FEMS microbiology letters,
Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
January 1994, Progress in industrial microbiology,
Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
September 1984, Current genetics,
Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
June 1998, Microbiology and molecular biology reviews : MMBR,
Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
October 2007, Journal of bacteriology,
Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
June 1992, European journal of biochemistry,
Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
April 1999, Current opinion in microbiology,
Karan Gautam Kaval, and Margo Gebbie, and Jonathan R Goodson, and Melissa R Cruz, and Wade C Winkler, and Danielle A Garsin
November 2012, Biotechnology for biofuels,
Copied contents to your clipboard!